A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.

Researchers at Vanderbilt University Medical Center have demonstrated the potential for large language models like ChatGPT to help generate electronic health record phenotyping algorithms, a critical but time-consuming task in observational health research.

Artificial intelligence programs outperformed doctors at answering typical patient questions — suggesting they could be used to write first-draft responses and help speed doctors’ work.

Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the U.S.

The 5th Annual Vanderbilt Alzheimer's Disease Research Day, sponsored by the Vanderbilt Memory and Alzheimer's Center (VMAC), was held April 10 at Vanderbilt University School of Nursing.

In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol.